Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...
Read Full NewsHistorical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.
New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.
Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.
1.
Universal screening approach achieves a comparable detection rate of lung cancer
2.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
3.
New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations
4.
Stereotactic Radiation Linked to Better Brain Mets Outcomes
5.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
1.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
2.
Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment
3.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
4.
A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%
5.
Understanding the HAS-BLED Score: What It Is and Why It Matters
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge